The present review is based on a critical literature revision and aimed to identify the overall clinical behavior of laryngeal solitary fibrous tumor (SFT). Laryngeal hemangiopericytomas (HPC) were included, according to both their re-classification as the SFT's cellular variant and the NAB2-STAT6 fusion gene. A case series was builded including a new case and other 30 previously published cases of laryngeal SFTs (Medline 1956 to 2021) with comparative purpose. Immunohistochemistry and molecular analysis were performed on the new case. The clinical features of such case series showed a peculiar behavior of SFT, characterized by 1) Early symptomatic onset 2) Small size at diagnosis 3) Prevalent supra-glottic location 4) Impairment of the quality of voice with vocal muscle sparing 5) Favorable clinical outcome after complete surgical excision, since no distant metastases were reported in the literature. Furthermore, atypical histologic features were infrequently described. As seen in the pleural counterpart and in other extra-pleural locations, laryngeal SFT harboured NAB2-STAT6 gene fusion and showed a strong nuclear immunostaining for STAT6, as confirmed by the herein described case. According to its peculiar clinicalpathologic behavior, the risk stratification models that have been proposed for SFT are not suitable for the larynx.